ANI Pharmaceuticals, Inc. company logo
ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc. (ANIP) EBITDA

Annual EBITDA

$63.12M$43.48M-40.79%

Summary

Current Value
As of today, ANIP annual EBITDA is $63.12M, down -40.79% on
Historical Performance
ANIP annual EBITDA is up +1925.71% over the past 3 years, and up +3.93% over the past 5 years
All-Time High Comparison
ANIP annual EBITDA is currently -40.79% below its historical high of $106.60M set on
3-Year Low Comparison
ANIP annual EBITDA is +152.08% above its 3-year low of $25.04M reached on an earlier date
Sector Comparison
ANIP annual EBITDA is higher than 84.89% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ANIP Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$63.12M-40.8%+1925.7%+3.9%+264.9%
Quarterly EBITDA$45.46M+1252.2%+216.3%+221.1%+506.0%
TTM EBITDA$144.84M+107.1%+2121.4%+547.8%+514.8%
Price$81.15+50.5%+84.6%+155.1%+31.1%
PE Ratio49.77
Annual Revenue$614.38M+26.2%+184.3%+197.4%+10000.0%
Annual EPS-$1.04-210.6%+69.3%-309.4%+97.9%
Annual EBIT-$4.61M-109.8%+89.6%-128.6%+88.0%
Annual Net Income-$18.52M-198.6%+56.5%-408.9%+61.0%

EBITDA Highs

ANIP Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$106.60M-40.8%
5Y$106.60M-40.8%
All$106.60M-40.8%

EBITDA Lows

ANIP Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$25.04MN/A+152.1%
5Y$3.12M+1925.7%
All-$50.78M+224.3%

EBITDA History

YearValueChange
$63.12M-40.8%
$106.60M+325.7%
$25.04M+703.6%
$3.12M-88.9%
$28.13M-53.7%
$60.74M-11.4%
$68.55M+21.7%
$56.31M+33.0%
$42.35M+6.8%
$39.64M+64.9%
$24.04M+1,311.9%
$1.70M+106.3%
-$27.23M+46.4%
-$50.78M-12.0%
YearValueChange
-$45.34M-18.4%
-$38.29M-113.1%
-$17.97M-109.2%
-$8.59M-341.5%
$3.56M+138.7%
-$9.20M+24.4%
-$12.16M-104.3%
-$5.95M-60.1%
-$3.72M-39.0%
-$2.68M+19.3%
-$3.31M-118.9%
-$1.51M+39.9%
-$2.52M-

FAQ

  • What is the current annual EBITDA of ANIP?

    As of today, ANIP annual EBITDA is $63.12M

  • What is 1-year change in ANIP annual EBITDA?

    ANIP annual EBITDA is down -40.79% year-over-year

  • What is 3-year change in ANIP annual EBITDA?

    ANIP annual EBITDA is up +1925.71% over the past 3 years

  • How far is ANIP annual EBITDA from its all-time high?

    ANIP annual EBITDA is currently -40.79% below its historical high of $106.60M set on December 31, 2023

  • How does ANIP annual EBITDA rank versus sector peers?

    ANIP annual EBITDA is higher than 84.89% of companies in Healthcare sector

  • When is ANIP next annual earnings release?

    The next annual earnings release for ANIP is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. ANIP Official Website www.anipharmaceuticals.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1023024/000102302425000108/0001023024-25-000108-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1023024/000102302425000015/0001023024-25-000015-index.htm
  4. ANIP Profile on Yahoo Finance finance.yahoo.com/quote/ANIP
  5. ANIP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anip